STOCKHOLM, Aug. 19, 2021 /PRNewswire/ The second quarter in figures Net sales amounted to TSEK 2,258 (1,683). The loss after tax amounted to TSEK 11,151 (8,864). The loss per share amounted
Benralizumab Promising for Rhinosinusitis With Nasal Polyps medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
SciBase - Interim report
January 1 - March 31, 2021
The first quarter in figures
Net sales amounted to TSEK 2,562 (2,469).
The loss after tax amounted to TSEK 8,153 (8,936).
The loss per share amounted to SEK 0.15 (0.54).
The cash flow from current operations was negative in the amount of TSEK 9,473 (7,893).
The gross margin reached 52.7% (54.0%).
Electrode sales volume increased by 14% and reached 7,496 (6,562) units, a new quarterly high. Repeat sales of electrodes to existing customers increased by 18%.
Important events during the quarter
Covid-19 continues to affect sales and the market situation remains difficult to predict going forward, due to ongoing lockdowns and reduced marketing activities. Sales in the company s key market Germany increased by 3%(cleared for currency effects +9%) while overall sales increased by 3% (cleared for currency effects +9%).
Defective epithelial barrier responsible for up to two billion chronic diseases
Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to many of these substances damages the epithelium, the thin layer of cells that covers the surface of our skin, lungs and intestine. Defective epithelial barriers have been linked to a rise in almost two billion allergic, autoimmune, neurodegenerative and psychiatric diseases.
Epithelial cells form the covering of most internal and external surfaces of the human body. This protective layer acts as a defense against invaders - including bacteria, viruses, environmental toxins, pollutants and allergens. If the skin and mucosal barriers are damaged or leaky, foreign agents such as bacteria can enter into the tissue and cause local, often chronic inflammation. This has both direct and indirect consequences.
A new study links defective epithelial barriers to a rise in almost two billion allergic, autoimmune, neurodegenerative, and psychiatric diseases.
Epithelial cells form the covering of most internal and external surfaces of the human body. This protective layer acts as a defense against invaders including bacteria, viruses, environmental toxins, pollutants and allergens.
If the skin and mucosal barriers are damaged or leaky, foreign agents such as bacteria can enter into the tissue and cause local, often chronic inflammation with both direct and indirect consequences.
“The epithelial barrier hypothesis proposes that damages to the epithelial barrier are responsible for up to two billion chronic, non-infectious diseases,” says Cezmi Akdis, director of the Swiss Institute of Allergy and Asthma Research (SIAF), which is associated with the University of Zurich.